Literature DB >> 32604409

Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid.

Valerie A Novakovic1, Gary E Gilbert1,2,3.   

Abstract

Recent reports indicate that suspended skeletal and cardiac myosin, such as might be released during injury, can act as procoagulants by providing membrane-like support for factors Xa and Va in the prothrombinase complex. Further, skeletal myosin provides membrane-like support for activated protein C. This raises the question of whether purified muscle myosins retain procoagulant phospholipid through purification. We found that lactadherin, a phosphatidyl-l-serine-binding protein, blocked >99% of prothrombinase activity supported by rabbit skeletal and by bovine cardiac myosin. Similarly, annexin A5 and phospholipase A2 blocked >95% of myosin-supported activity, confirming that contaminating phospholipid is required to support myosin-related prothrombinase activity. We asked whether contaminating phospholipid in myosin preparations may also contain tissue factor (TF). Skeletal myosin supported factor VIIa cleavage of factor X equivalent to contamination by ∼1:100 000 TF/myosin, whereas cardiac myosin had TF-like activity >10-fold higher. TF pathway inhibitor inhibited the TF-like activity similar to control TF. These results indicate that purified skeletal muscle and cardiac myosins support the prothrombinase complex indirectly through contaminating phospholipid and also support factor X activation through TF-like activity. Our findings suggest a previously unstudied affinity of skeletal and cardiac myosin for phospholipid membranes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32604409      PMCID: PMC7685214          DOI: 10.1182/blood.2020005930

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor protein C.

Authors:  Djuro Josic; Lutz Hoffer; Andrea Buchacher
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-06-25       Impact factor: 3.205

2.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

3.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors:  T A Drake; J H Morrissey; T S Edgington
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  Single bilayer liposomes.

Authors:  S M Johnson; A D Bangham; M W Hill; E D Korn
Journal:  Biochim Biophys Acta       Date:  1971-06-01

5.  Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.

Authors:  Jevgenia Zilberman-Rudenko; Hiroshi Deguchi; Meenal Shukla; Yoshimasa Oyama; Jennifer N Orje; Zihan Guo; Tine Wyseure; Laurent O Mosnier; Owen J T McCarty; Zaverio M Ruggeri; Tobias Eckle; John H Griffin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-27       Impact factor: 8.311

6.  Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature.

Authors:  Jialan Shi; Christian W Heegaard; Jan T Rasmussen; Gary E Gilbert
Journal:  Biochim Biophys Acta       Date:  2004-11-17

7.  Direct binding of myosin II to phospholipid vesicles via tail regions and phosphorylation of the heavy chains by protein kinase C.

Authors:  N Murakami; M Elzinga; S S Singh; V P Chauhan
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

8.  Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase.

Authors:  W F Skogen; C T Esmon; A C Cox
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

9.  Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites.

Authors:  Jialan Shi; Gary E Gilbert
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

10.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

View more
  5 in total

Review 1.  Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.

Authors:  Hiroshi Deguchi; Shravan Morla; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-10-25       Impact factor: 5.824

2.  Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids.

Authors:  Shravan Morla; Hiroshi Deguchi; José A Fernández; Wolfram Ruf; Rolf A Brekken; John H Griffin
Journal:  Blood       Date:  2021-04-01       Impact factor: 22.113

Review 3.  Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation.

Authors:  Stuart E Lind
Journal:  Heliyon       Date:  2021-01-20

4.  Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation.

Authors:  Shravan Morla; Hiroshi Deguchi; Jevgenia Zilberman-Rudenko; András Gruber; Owen J T McCarty; Priyanka Srivastava; David Gailani; John H Griffin
Journal:  J Biol Chem       Date:  2022-01-07       Impact factor: 5.157

5.  SkM-ing information from traumatized tissue.

Authors:  Philip J Crispin; Philip Y Choi; Elizabeth E Gardiner
Journal:  J Thromb Haemost       Date:  2022-06       Impact factor: 16.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.